Duloxetine delayed-release capsules, USP 30 mg are size '3' hard gelatin capsules having blue cap and milky white body, imprinted as '30 mg' on the body with black ink and '1110' on the cap with white ink, containing off white to reddish brown colored pellets.

Bottles of 30                             NDC 13668-110-30

Bottles of 100                           NDC 13668-110-01

Bottles of 500                           NDC 13668-110-05

 Bottles of 1400                      NDC 13668-110-14

100 Unit dose capsules NDC 13668-110-74

            Duloxetine delayed-release capsules, USP 60 mg are size '1' hard gelatin capsules having opaque blue cap and yellow body, imprinted as '60 mg' on the body and '1111' on the cap with white ink, containing off white to reddish brown colored pellets.

Bottles of 30                             NDC 13668-111-30

Bottles of 100                           NDC 13668-111-01

Bottles of 500                           NDC 13668-111-05

 Bottles of 1000                       NDC 13668-111-10

100 Unit dose capsules NDC 13668-111-74
16.2 Storage and Handling
 
Store at 20° to 25°C (68° to 77°); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].
17 PATIENT COUNSELING INFORMATION
See FDA-approved patient labeling (Medication Guide).
Information on Medication Guide– Inform patients, their families, and their caregivers about the benefits and risks associated with treatment with duloxetine delayed-release capsules and counsel them in its appropriate use. A patient Medication Guide is available for duloxetine delayed-release capsules. Instruct patients, their families, and their caregivers to read the Medication Guide before starting duloxetine delayed-release capsules and each time their prescription is renewed, and assist them in understanding its content